Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.

[1]  J. Lurain,et al.  Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. , 2005, Gynecologic oncology.

[2]  A. Mitsuhashi,et al.  Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy , 2005 .

[3]  D. Fishman,et al.  Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. , 2003, Gynecologic oncology.

[4]  M. Carney.  Treatment of low risk gestational trophoblastic disease. , 2003, Clinical obstetrics and gynecology.

[5]  Jason D. Wright,et al.  Treatment of High-Risk Gestational Trophoblastic Tumors , 2003, Clinical obstetrics and gynecology.

[6]  J. Lurain.  Advances in management of high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[7]  R. Berkowitz,et al.  Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. , 2002, The Journal of reproductive medicine.

[8]  G. Rustin,et al.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Kwon,et al.  Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. , 2001, Gynecologic oncology.

[10]  S. Sekiya,et al.  Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. , 2000, Gynecologic oncology.

[11]  S. J. Kim,et al.  Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. , 1998, Gynecologic oncology.

[12]  E S Newlands,et al.  EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Berkowitz,et al.  The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D. , 1997, Gynecologic oncology.

[14]  E. Newlands,et al.  Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Hoffman,et al.  A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. , 1996, Gynecologic oncology.

[16]  A. Berchuck,et al.  Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease , 1994, Obstetrics and gynecology.

[17]  R. Berkowitz,et al.  Brain metastases of gestational trophoblastic tumor. , 1992, The Journal of reproductive medicine.

[18]  M. Amer,et al.  Liver metastases of gestational trophoblastic tumor. , 1993, Gynecologic oncology.

[19]  A. Rademaker,et al.  Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high‐risk gestational trophoblastic disease , 1992, Obstetrics and gynecology.

[20]  E. Newlands,et al.  Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989 , 1991, British journal of obstetrics and gynaecology.

[21]  E. Surwit,et al.  High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen. , 1991, The Journal of reproductive medicine.

[22]  R. Berkowitz,et al.  Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. , 1990, Gynecologic oncology.

[23]  C. Théodore,et al.  Treatment of high‐risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide , 1989, Cancer.

[24]  L. Twiggs,et al.  A Prospective Randomized Comparison of Methotrexate, Dactinomycin, and Chlorambucil Versus Methotrexate, Dactinomycin, Cyclophosphamide, Doxorubicin, Melphalan, Hydroxyurea, and Vincristine in “Poor Prognosis” Metastatic Gestational Trophoblastic Disease: A Gynecologic Oncology Group Study , 1989, Obstetrics and gynecology.

[25]  F. Landoni,et al.  EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). , 1988, Gynecologic oncology.

[26]  H. Ma,et al.  Primary oral etoposide therapy in gestational trophoblastic disease: An update , 1986, Cancer.

[27]  E. Newlands,et al.  Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984) , 1986, British journal of obstetrics and gynaecology.